Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Jul 30, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson has given company President Vincent Forlenza the additional job of chief operating officer, and it has added Christopher Jones to serve on its board of directors. "This new title reflects the additional duties that Vince has taken on during the last two years and the key role he continues to play in developing and implementing BD's strategy and vision," said BD Chairman and CEO Edward Ludwig in a statement. Jones is a partner and director at Cognetas, a director of Central Trust, and he chairs the board of the Pavilion Clinic and has been a member of the Johns Hopkins Bloomberg School of Public Health’s Health Advisory Board.

Fred Tenover has been appointed as senior director of scientific affairs at Cepheid, the company said recently. Tenover will serve as a liaison with the infection control community and will lead Cepheid's healthcare-associated infection consortium program. He currently holds the position of distinguished consultant and director of the office of antimicrobial resistance at the US Centers for Disease Control and Prevention.

London Genetics announced last week the appointment of two senior advisers, Stephen DeCherney and Munir Pirmohamed. DeCherney, professor of medicine at the University of North Carolina, was previously president of the Global Clinical Organisation, and chief innovation officer at Quintiles Translational. Pirmohamed is the National Health Service chair of pharmacogenetics at the University of Liverpool and is involved in a warfarin pharmacogenetics study involving 2,000 patients, called EU-PACT Phase IV study.

Andrei Grigoriev has been appointed to be director of the Center for Computational and Integrative Biology and a professor of biology at Rutgers University – Camden. Grigoriev formerly was scientific director at GPC Biotech, where he started a bioinformatics department. At the Center, Grigoriev will be responsible for developing the multidisciplinary research center at Rutgers, which will have a team of around 30 associate members.

Pressure Biosciences has elected Gregory Freitag to serve on its board of directors. He is CEO, CFO, and a director of LecTec, and he is CEO of EmployRx. He also has been in business development at Pfizer Health Solutions and at Guidant. He co-founded and was CEO of HTS Biosystems, and he was COO, CFO, and general counsel at Quantech.

Arrayit and its Arrayit Diagnostics subsidiary have hired Duane Steele to develop strategic alliances with pharmaceutical companies for the OvaDx panel. Steele formerly was VP of business development of IVAX Diagnostics and COO of Diamedix.

GenomeQuest has appointed Anthony Flynn to be chief marketing officer. Flynn, who formerly was CMO at Bentley Systems, will handle marketing for the company’s whole and multi-genome analysis offering.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.